XML 14 R4.htm IDEA: XBRL DOCUMENT v3.23.2
Condensed Statements of Operations - USD ($)
 3 Months Ended 6 Months Ended
Jun. 30, 2023
Jun. 30, 2022
Jun. 30, 2023
Jun. 30, 2022
Operating Expenses:        
Research and development $ 2,811,061 $ 3,586,866 $ 5,333,011 $ 7,299,450
General and administrative 3,149,809 3,534,590 6,086,695 7,009,555
Total Operating Expenses 5,960,870 7,121,456 11,419,706 14,309,005
Loss From Operations (5,960,870) (7,121,456) (11,419,706) (14,309,005)
Other Income (Expense):        
Other income, net 119,450 33,376 190,443 26,303
Interest expense (558,003) (153,436) (1,012,006) (298,673)
Interest income 183,563 2,416 286,043 2,610
Net Loss $ (6,215,860) $ (7,239,100) $ (11,955,226) $ (14,578,765)
Net Loss Per Share        
Net Loss Per Share - Basic $ (0.16) $ (0.22) $ (0.32) $ (0.46)
Net Loss Per Share - Diluted $ (0.16) $ (0.22) $ (0.32) $ (0.46)
Weighted Average Number of Common Shares Outstanding        
Weighted Average Number of Common Shares Outstanding - Basic 38,093,826 33,644,867 37,753,694 31,836,582
Weighted Average Number of Common Shares Outstanding - Diluted 38,093,826 33,644,867 37,753,694 31,836,582